Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04901897 · ClinicalTrials.gov registry record · NA

Product Performance of a New Silicone Hydrogel Contact Lens

A NA study of Myopia, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
805
Enrollment target
20
Study locations

NCT04901897 is a NA study of Myopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 805 participants, above the 259-participant average among 90 other Myopia trials with a reported enrollment target (211% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04901897, a NA study of Myopia, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
805 participants
Enrollment target
20
Study locations

Study Summary

The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft contact lens wearers on a daily disposable wear basis.

Conditions Studied

Myopia

Interventions

  • DEVICE senofilcon A
  • DEVICE delefilcon A
  • DEVICE kalifilcon A

Study Locations (20)

California

  • Bausch Site 406 - Azusa
  • Bausch Site 430 - Los Angeles
  • Bausch Site 419 - San Diego
  • Bausch Site 435 - San Francisco
  • Bausch Site 432 - Sunnyvale
  • Bausch Site 409 - Torrance

Florida

  • Bausch Site 415 - Jacksonville
  • Bausch Site 434 - Jacksonville
  • Bausch Site 405 - Sarasota

Hawaii

  • Bausch Site 437 - Honolulu
  • Bausch Site 401 - ‘Aiea

Alabama

  • Bausch Site 433 - Birmingham

Arizona

  • Bausch Site 431 - Scottsdale

Colorado

  • Bausch Site 416 - Denver

Georgia

  • Bausch Site 412 - Decatur

Kansas

  • Bausch Site 414 - Leavenworth

Trial Details

FieldValue
Enrollment Target 805 participants
Start Date 2019-07-31
Est. Completion 2019-10-09
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04901897

The ClinicalTrials.gov registry entry for NCT04901897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 805 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 90 other Myopia trials with a reported enrollment target (211% higher). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 3 interventions - of which senofilcon A is the first listed.

NCT04901897 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Hawaii.

Frequently Asked Questions

What is clinical trial NCT04901897 about?

NCT04901897 is a clinical study titled "Product Performance of a New Silicone Hydrogel Contact Lens". The objective of this study is to evaluate the product performance of kalifilcon A, compared to the Johnson \& Johnson Acuvue Oasys® 1-Day with HydraLuxe™ (senofilcon A) daily disposable contact lens and Alcon DAILIES TOTAL1® (delefilcon A) daily disposable contact lenses when worn by current soft c...

What is the current status of trial NCT04901897?

This trial is currently completed. It is a NA study. The enrollment target is 805 participants. The study started on 2019-07-31. Estimated completion is 2019-10-09.

What conditions does trial NCT04901897 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT04901897?

The interventions under investigation include: senofilcon A (DEVICE), delefilcon A (DEVICE), kalifilcon A (DEVICE).

Who is sponsoring clinical trial NCT04901897?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04901897 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.